Medication info

Yuhan Hydrochloride Ranitidine Tablet 150 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 199200613 · Notified 1992.07.06

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
1. Adults: Administer ranitidine 150 mg per dose orally 2 times daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine per dose orally 2 times daily, or 300 mg once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose 2 times daily, in the morning and at bedtime. The same dosage and administration apply to concomitant treatment of ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Ulcers usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine per dose 2 times daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg of this medicine per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer 150 mg of this medicine per dose 2 times daily. 5) Premedication (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Since hemodialysis reduces the blood concentration of the drug, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
For patients 12 years of age and older, administer 75 mg of this medicine per dose orally 2 times daily (for oral solution only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg per kg of body weight) may be administered 2 times daily.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcer
  • gastric ulcer due to NSAID use
  • duodenal ulcer
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
View approved original text

This medication is used for various gastrointestinal disorders such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is administered prior to surgery to prevent Mendelson's syndrome and is effective in treating ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It also aids in improving gastric mucosal lesions during acute exacerbations of acute and chronic gastritis and upper gastrointestinal bleeding. Additionally, it is used to relieve symptoms of heartburn or acid regurgitation due to excessive stomach acid. It is used to effectively improve symptoms and lesions of various gastric diseases.

How to take

Adult dose

1. Adults: Administer ranitidine 150 mg per dose orally 2 times daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine per dose orally 2 times daily, or 300 mg once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose 2 times daily, in the morning and at bedtime. The same dosage and administration apply to concomitant treatment of ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Ulcers usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine per dose 2 times daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg of this medicine per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer 150 mg of this medicine per dose 2 times daily. 5) Premedication (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Since hemodialysis reduces the blood concentration of the drug, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

For patients 12 years of age and older, administer 75 mg of this medicine per dose orally 2 times daily (for oral solution only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg per kg of body weight) may be administered 2 times daily.

Precautions

This drug should not be used in patients who have had allergic reactions to it or have a history of acute porphyria. In patients with poor kidney function, the concentration of this drug may increase, so caution should be taken in dosage adjustment or extending dosing intervals. Special care is needed for patients with impaired liver function, a history of drug allergies, and the elderly. When taken in conjunction with non-steroidal anti-inflammatory drugs, particularly the elderly or those with a history of peptic ulcers should be monitored regularly. Since it may mask symptoms of gastric cancer, patients with gastric ulcers or newly presenting dyspeptic symptoms over the age of 40 should be evaluated to rule out malignancy prior to treatment. For patients with Helicobacter pylori infection and gastric or duodenal ulcers, bacterial eradication therapy should be conducted concurrently. This drug may rarely cause serious allergic reactions, blood abnormalities, liver dysfunction, heart problems, gastrointestinal symptoms, or neurological symptoms, so if any unusual symptoms occur, its use should be stopped immediately, and a doctor should be consulted. During treatment, it is important to conduct regular blood tests and liver and kidney function tests to monitor for abnormalities. Elderly patients, those with chronic lung diseases, diabetic patients, and immunocompromised patients may have an increased risk of pneumonia, so caution is warranted. If dizziness or drowsiness occurs after taking this medication, driving or operating dangerous machinery should be avoided. There may be interactions with other medications, so particularly when taking anticoagulants such as warfarin, blood coagulation status should be closely monitored. Taking this medication with high doses of sucralfate may reduce absorption; therefore, it is recommended to take them with a 2-hour interval. Pregnant women or those who may become pregnant should carefully consider the necessity and risks of taking this medication. If breastfeeding, this medication may be transferred into breast milk, so it should only be used when necessary. Safety in children has not been sufficiently confirmed, so caution is necessary in use. Elderly patients may experience increased blood levels of the drug due to reduced kidney function, requiring dosage adjustment and extended intervals between doses. This drug may cause false positive reactions in some tests, so care should be taken with the testing methods. In cases of overdose, appropriate measures such as vomiting or gastric lavage are essential, and if needed, the drug can be removed via hemodialysis. Store safely out of the reach of children and do not transfer to another container. This drug reduces acid secretion, which can promote the growth of bacteria in the stomach; therefore, additional monitoring such as ophthalmic exams may be needed with long-term use.

Side effects

Anaphylactic shock, urticaria, angioedema, rash, fever, bronchospasm, hypotension, chest pain, granulocytopenia, elevated serum creatinine, leukopenia, thrombocytopenia, bone marrow hypoplasia, aplastic anemia, aplastic anemia, dyskeratosis congenita, hypereosinophilia, generalized malaise, weakness, subcutaneous and mucosal bleeding, fever, liver dysfunction (elevated AST, ALT, γ-GTP, ALP), jaundice, hepatitis, bradycardia, heart block, tachycardia, vasculitis, constipation, nausea, vomiting, abdominal distension, abdominal pain, loss of appetite, diarrhea, acute pancreatitis, dizziness, drowsiness, convulsions, headache, heaviness in the head, insomnia, agitation, anxiety, mental confusion, depression, hallucinations, blurred vision, involuntary movement disorders, altered consciousness, hepatomegaly muscle spasms, gynecomastia, galactorrhea, erectile dysfunction, decreased libido, arthralgia, myalgia, rhabdomyolysis, skin rash, erythema multiforme, alopecia, glossitis, skin itching, mucocutaneous syndrome, toxic epidermal necrolysis, acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius. Avoid storing in excessively hot or cold places.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.